HansBiomed (Korea) Today
| 042520 Stock | KRW 13,460 30.00 0.22% |
Performance4 of 100
| Odds Of DistressLess than 9
|
HansBiomed is trading at 13460.00 as of the 18th of April 2024, a 0.22 percent increase since the beginning of the trading day. The stock's open price was 13430.0. HansBiomed has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for HansBiomed are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of May 2023 and ending today, the 18th of April 2024. Click here to learn more.
HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. HansBiomed Corporation was founded in 1993 and is based in Seoul, South Korea. The company has 8.95 M outstanding shares. More on HansBiomed
Moving together with HansBiomed Stock
| 0.72 | 029780 | Samsung Card Earnings Call This Week | PairCorr |
| 0.64 | 086790 | Hana Financial Earnings Call This Week | PairCorr |
Moving against HansBiomed Stock
| 0.42 | 021240 | COWAY | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
HansBiomed Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. HansBiomed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding HansBiomed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Ho Hwang |
| Business Concentration | Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
HansBiomed (042520) is traded on KOSDAQ in Korea and employs 15 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 112.74 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HansBiomed's market, we take the total number of its shares issued and multiply it by HansBiomed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. HansBiomed operates under Biotechnology sector and is part of Health Care industry. The entity has 8.95 M outstanding shares.
HansBiomed has accumulated about 7.52 B in cash with (4.27 B) of positive cash flow from operations.
Check HansBiomed Probability Of Bankruptcy
Ownership AllocationThe market capitalization of HansBiomed is W112.74 Billion. HansBiomed secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check HansBiomed Ownership Details
HansBiomed Stock Price Odds Analysis
What are HansBiomed's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of HansBiomed jumping above the current price in 90 days from now is about 43.17%. The HansBiomed probability density function shows the probability of HansBiomed stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon HansBiomed has a beta of 0.3167. This suggests as returns on the market go up, HansBiomed average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding HansBiomed will be expected to be much smaller as well. Additionally, hansBiomed has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of HansBiomed to move above the current price in 90 days from now is about 43.17 (This HansBiomed probability density function shows the probability of HansBiomed Stock to fall within a particular range of prices over 90 days) .
HansBiomed Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. HansBiomed market risk premium is the additional return an investor will receive from holding HansBiomed long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in HansBiomed. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although HansBiomed's alpha and beta are two of the key measurements used to evaluate HansBiomed's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.54 | |||
| Standard Deviation | 3.58 | |||
| Variance | 12.83 | |||
| Risk Adjusted Performance | 0.0039 |
HansBiomed Stock Against Markets
Picking the right benchmark for HansBiomed stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in HansBiomed stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for HansBiomed is critical whether you are bullish or bearish towards HansBiomed at a given time. Please also check how HansBiomed's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in HansBiomed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
HansBiomed Corporate Directors
HansBiomed corporate directors refer to members of a HansBiomed board of directors. The board of directors generally takes responsibility for the HansBiomed's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of HansBiomed's board members must vote for the resolution. The HansBiomed board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.How to buy HansBiomed Stock?
Before investing in HansBiomed, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in HansBiomed. To buy HansBiomed stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of HansBiomed. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase HansBiomed stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located HansBiomed stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased HansBiomed stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as HansBiomed, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in HansBiomed?
The danger of trading HansBiomed is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of HansBiomed is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than HansBiomed. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile HansBiomed is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in HansBiomed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the HansBiomed information on this page should be used as a complementary analysis to other HansBiomed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for HansBiomed Stock analysis
When running HansBiomed's price analysis, check to measure HansBiomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HansBiomed is operating at the current time. Most of HansBiomed's value examination focuses on studying past and present price action to predict the probability of HansBiomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HansBiomed's price. Additionally, you may evaluate how the addition of HansBiomed to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |